Stay updated on Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.

Latest updates to the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now displays an updated revision tag (Revision: v3.6.3), replacing the previous Revision: v3.6.2.SummaryDifference0.1%

- Check18 days agoChange DetectedA new revision tag (v3.6.2) was added and the previous tag (v3.6.0) removed, indicating a platform software update.SummaryDifference0.1%

- Check32 days agoChange DetectedRecruitment status now shows no more participants; new user guidance sections were added, and the Intervention/Treatment header formatting was updated to reflect the current structure of the study details.SummaryDifference0.4%

- Check39 days agoChange DetectedThe study record shows a new revision (v3.5.5) replacing the previous revision (v3.5.4), indicating an updated page version rather than new study data.SummaryDifference0.1%

- Check61 days agoChange DetectedThe footer revision label was updated from v3.5.3 to v3.5.4, indicating a small build/version update.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site software update rather than a change to the clinical trial information.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.